Skip to content

Comparison of 3 Different Density Levobupivacaine Solutions + Fentanyl for Spinal Anaesthesia for Caesarean Delivery.

Comparison of the Efficacy of 3 Different Density Levobupivacaine Solutions + Fentanyl Applied Intrathecally for Spinal Anesthesia in Caesarean Delivery.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03956303
Enrollment
100
Registered
2019-05-20
Start date
2014-06-30
Completion date
2016-08-31
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Keywords

Anesthesia, Spinal, Cesarean Section, Levobupivacaine

Brief summary

The investigator's aim is to compare the efficacy of 3 levobupivacaine solutions with different density on spinal anesthesia for caesarean delivery.

Detailed description

Patients scheduled for elective caesarean delivery were separated into 4 groups. Spinal anesthesia was performed with one of the following regimens. Group 1: Levobupivacaine 8 mg + 20 mcg Fentanyl Group 2: Levobupivacaine 8 mg + 20 mcg Fentanyl + 40 mg Dextrose Group 3: Levobupivacaine 8 mg + 20 mcg Fentanyl + 60 mg Dextrose Group 4: Levobupivacaine 8 mg + 20 mcg Fentanyl + 80 mg Dextrose After anesthesia induction motor block was evaluated via bromage scale and sensory block via pinprick test every 3 minutes for the first 15 minutes, and every 5 minutes up to 60 minutes. Maximum sensory block level, time to reach maximum block level, time needed to achieve T10 sensory level were recorded. Baby delivery time, and operation duration were also recorded. Time to two segment regression of maximum sensory block, motor block recovery time and time to S2 regression of sensory block will be recorded. Hemodynamic data, nausea vomiting, were also recorded throughout surgery at the same evaluation periods and postoperative period. The surgeon will also evaluate the abdominal relaxation surgical block quality as good, medium and poor. The patient will evaluate spinal block analgesia quality as good, medium or poor. Pain scores are going to be evaluated by VAS at the beginning, uterine incision and during abdominal closure. Time for first analgesic requirement and postoperative pain is also going to be evaluated by VAS.

Interventions

DRUGChirocaine %0.5

Levobupivacaine 8 mg Chirocaine (% 0.5) +20 mcg fentanyl

DRUGChirocaine Heavy 40

Chirocaine (%0.75) + Dextrose 40 mg+20 mcg fentanyl

DRUGChirocaine Heavy 60

Chirocaine (%0.75) + Dextrose 60 mg+20 mcg fentanyl

DRUGChirocaine Heavy 80

Chirocaine (%0.75) + Dextrose 80 mg+20 mcg fentanyl

Sponsors

Balikesir University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* ASA I-II * Pregnancy at Term * Scheduled for elective caesarean delivery

Exclusion criteria

* contraindication for spinal anesthesia * drug allergy * pregnancy related disorders (hypertension, placenta previa, fetal problems)

Design outcomes

Primary

MeasureTime frameDescription
Change to regression of sensory block by pinprick testIn the postoperative period, changes in sensory block level will be recorded at 30 min intervals up to 2 hourstime to S2 regression of sensory block by pinprick test
time to reach maximum level of sensory block at intraoperative period by pinprick testEvery 3 minutes for 15 minutes and every 5 minutes afterwards up to 60 minutes after induction of spinal anesthesia. the time to reach the highest measured by pinprick test will be recorded.time to reach maximum level of sensory block by pinprick test
Change over time at the level of sensory block at intraoperative period by pinprick testEvery 3 minutes for 15 minutes and every 5 minutes afterwards up to 60 minutes after induction of spinal anesthesia. The time to two segment regression of maximum sensory block by pinprick test will be recorded.time to two segment regression of maximum sensory block by pinprick test
Change in motor block level from PACU to dischargeevery 15 minutes until end of surgery and 30 minutes postoperatively up to 2 hours by Bromage Scalemotor block recovery time by bromage scale
Change of time to reach T10 sensory spinal block level at intraoperative period by pinprick testEvery 3 minutes for 15 minutes and every 5 minutes afterwards up to 60 minutes after induction of spinal anesthesia.In these evaluation periods, the sensory block will be recorded when the T10 is detected.time to reach T10 sensory block by pinprick test
Spinal Block Quality by questioningAt the end of surgerythe intensity of spinal block will be evaluated via questioning the surgeon and the patient. the surgeon will grade the abdominal relaxivity as good, medium or poor The patient will evaluate spinal block analgesia quality as good, medium or poor.
Change the sensory block level at intraoperative period by pinprick testEvery 3 minutes for 15 minutes and every 5 minutes afterwards up to 60 minutes after induction of spinal anesthesia. The highest measured level by pinprick test be recordedthe level of maximum sensory block by pinprick test

Secondary

MeasureTime frameDescription
Number of participants with postoperative complications ( head ache, back pain, numbness of lower extremity )by phoneon postoperative day 3 by phone.postoperative complications ( head ache, back pain, numbness of lower extremity )by phone
evaluation of umbilical vein blood gas analysisimmediately after fetus deliveryumbilical vein blood sample will be obtained immediately after delivery of the fetus and will a blood gas analysis will be performed
Haemodynamic evaluation by mmHg for systolic , diastolic and mean arterial blood pressureEvery 3 minutes for 15 minutes and every 5 minutes afterwards up to 60 minutes after induction of spinal anesthesia. every 30 minutes up to 2 hoursmeasurement of systolic , diastolic and mean arterial blood pressure

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026